🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhi Wen

Zhuhai People's Hospital

ORCID: 0000-0002-0170-622X

Also affiliated with Hunan Mawangdui Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase”.

Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00046
N/A
0DataRank · unranked
118 citations

Hao Wu, Zhongrui Zhang, Eric D. Leisten, Xueqing Nie, Binkai Liu +5 more

Expression of Nras Q61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice

Blood(2020)10.1182/blood.2020007156
N/A
0DataRank · unranked
44 citations

Adhithi Rajagopalan, Evan Flietner, Grant Yun, Marta Chesi, Quinlan Furumo +20 more

Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model

Scientific Reports(2022)10.1038/s41598-022-14114-z
N/A
0DataRank · unranked
15 citations

Zhi Wen, Adhithi Rajagopalan, Oisun Jung, Lyndsay Watkins, Joshua Wiesner +10 more

Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in NrasQ61R/+ mice

Leukemia(2022)10.1038/s41375-022-01510-7
N/A
0DataRank · unranked
4 citations

Remington Finn, Xin Gao, Lin Li, Alexander S. Hebert, Erik A. Ranheim +10 more

Ponatinib for RAS-Driven Multiple Myeloma: Efficacy in the High-Risk VQ Myeloma Model

Research Square(2022)10.21203/rs.3.rs-1296881/v1
N/A
0DataRank · unranked
0 citations

Zhi Wen, Adhithi Rajagopalan, Oisun Jung, Joshua Wiesner, Xiaona You +8 more

Genomic and transcriptional profiling stratifies VQ myeloma lines into two clusters with distinct risk signatures and drug responses

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.21.504657
N/A
0DataRank · unranked
0 citations

Mei Yu, Adhithi Rajagopalan, Yun Zhou, Yubin Feng, Anthony J. Veltri +9 more

Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses

Oncogene(2023)10.1038/s41388-023-02684-9
N/A
0DataRank · unranked
5 citations

Mei Yu, Govinda Poudel, Anthony J. Veltri, Yun Zhou, Adhithi Rajagopalan +10 more

Orphan nuclear receptor NR2E3 and its small-molecule agonist induce cancer cell apoptosis through regulating p53, IFNα and MYC pathways

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.26.573366
N/A
0DataRank · unranked
0 citations

Todd G. Kroll, Linhui Hao, Ansul Sharma, Vivian Zhou, Luke F. Moat +12 more

Inhibition of FOXM1 synergizes with BCL2 inhibitor Venetoclax in killing non-t(11;14) multiple myeloma cells via repressing MYC pathway

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.27.613548
N/A
0DataRank · unranked
0 citations

Siegfried Janz, Yidan Wang, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Sung Hoon Kim +2 more

Orphan nuclear receptor NR2E3 is a new molecular vulnerability in solid tumors by activating p53

Cell Death and Disease(2025)10.1038/s41419-025-07337-1
N/A
0DataRank · unranked
6 citations

Todd G. Kroll, Linhui Hao, Zhi Wen, Yidan Wang

Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway

Advanced Science(2025)10.1002/advs.202508822
N/A
0DataRank · unranked
3 citations

Yidan Wang, Kathryn Fox, Adam Bissonnette, Luke F. Moat, Terrie Kitchner +12 more